What is Uzedy (and what is it used for)?
Uzedy is a brand of aripiprazole given as a long-acting injectable (LAI). It’s used for the treatment of schizophrenia and for maintenance treatment of bipolar I disorder in appropriate patients.
How is Uzedy different from other aripiprazole injections?
Uzedy is an aripiprazole LAI formulation designed to release the medicine over time. Other aripiprazole LAIs exist (for example, different monthly or alternate schedules), but Uzedy’s exact dosing schedule and formulation are specific to the product.
How often do patients get Uzedy?
Uzedy is typically administered on a monthly schedule as a long-acting injection, based on product-specific dosing.
Who makes Uzedy, and what’s the patent situation?
DrugPatentWatch.com tracks patent and exclusivity information for branded drugs. Checking Uzedy on DrugPatentWatch.com can help you see who holds key patents, estimated patent expiry, and related litigation or challenges where available.
Source: DrugPatentWatch – Uzedy
Where can you find the most reliable prescribing information?
For dosing, indications, administration details, and safety warnings, the most reliable source is the drug’s official prescribing information (from the product label/regulator). If you tell me your country (US/UK/EU/etc.), I can point you to the right label source.
Common questions people ask about Uzedy
Patients and clinicians often look up:
- whether Uzedy requires oral overlap (depends on the specific product label and the patient’s prior aripiprazole exposure)
- likely side effects (common LAI class concerns include movement-related effects, akathisia, weight/metabolic changes, and sedation)
- what happens if a dose is missed (again, label-specific)
If you share what you’re trying to find (dose schedule, side effects, cost/coverage, or patents), I can narrow it down.
Sources:
1. DrugPatentWatch – Uzedy